OrphAI Therapeutics

New Haven, CT · Founded 2013 · Privately Held (backing)

Developer of a precision therapeutics technology designed to treat cancer and rare diseases. OrphAI Therapeutics is based in New Haven, CT and was founded in 2013. Its last known valuation is $300 million. It has raised $155 million.

Last price · $/share
—
Implied valuation
$300.0M
Total raised
$154.5M
Last round
—

Who backs OrphAI Therapeutics?

7 investors
InvestorType
YuanBio Venture CapitalVenture capital
Yonghua CapitalOther
4Catalyzer—
Albany Capital (Australia)—
Gravity Ventures (Korea)—
Shenzhen Sangel Venture Capital—
Xiphos Bio—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

OrphAI Therapeutics investors

7 investors are on record for OrphAI Therapeutics, including YuanBio Venture Capital, Yonghua Capital, 4Catalyzer and Albany Capital (Australia).

Free account
More of OrphAI Therapeutics with a free account
  • ·Watch OrphAI Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like OrphAI Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View